Progress in CRF-1 Antagonist Drug Development for Anxiety and Depression
Updated review of CRF-1 receptor antagonist development for anxiety and depression, covering new compounds, clinical trial results, and reasons for mixed success — the continuing quest for stress peptide drugs.
Quick Facts
What This Study Found
Updated review of CRF-1 receptor antagonist development for anxiety and depression, covering new compounds, clinical trial results, and reasons for mixed success — the continuing quest for stress peptide drugs.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding Updated review of CRF-1 receptor antagonist development for anxiety and depression, covering new compounds, clinical trial results, and reasons for mi
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2010.
- Original Title:
- Progress in corticotropin-releasing factor-1 antagonist development.
- Published In:
- Drug discovery today, 15(9-10), 371-83 (2010)
- Authors:
- Zorrilla, Eric P(2), Koob, George F(5)
- Database ID:
- RPEP-01719
Evidence Hierarchy
Frequently Asked Questions
What was studied?
Progress in CRF-1 Antagonist Drug Development for Anxiety and Depression
What was found?
Updated review of CRF-1 receptor antagonist development for anxiety and depression, covering new compounds, clinical trial results, and reasons for mixed success — the continuing quest for stress peptide drugs.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01719APA
Zorrilla, Eric P; Koob, George F. (2010). Progress in corticotropin-releasing factor-1 antagonist development.. Drug discovery today, 15(9-10), 371-83. https://doi.org/10.1016/j.drudis.2010.02.011
MLA
Zorrilla, Eric P, et al. "Progress in corticotropin-releasing factor-1 antagonist development.." Drug discovery today, 2010. https://doi.org/10.1016/j.drudis.2010.02.011
RethinkPeptides
RethinkPeptides Research Database. "Progress in corticotropin-releasing factor-1 antagonist deve..." RPEP-01719. Retrieved from https://rethinkpeptides.com/research/zorrilla-2010-progress-in-corticotropinreleasing-factor1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.